EVEZ Stock Overview
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Evolva Holding SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF0.94 |
| 52 Week High | CHF17.10 |
| 52 Week Low | CHF0.62 |
| Beta | 0.20 |
| 1 Month Change | -6.07% |
| 3 Month Change | 36.81% |
| 1 Year Change | -94.61% |
| 3 Year Change | -98.00% |
| 5 Year Change | -98.37% |
| Change since IPO | -99.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| EVEZ | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -3.6% | 1.4% |
| 1Y | -94.6% | -37.7% | 1.1% |
Return vs Industry: EVEZ underperformed the UK Chemicals industry which returned -37% over the past year.
Return vs Market: EVEZ underperformed the UK Market which returned 0.6% over the past year.
Price Volatility
| EVEZ volatility | |
|---|---|
| EVEZ Average Weekly Movement | 19.1% |
| Chemicals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: EVEZ's share price has been volatile over the past 3 months.
Volatility Over Time: EVEZ's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 49 | n/a | www.evolva.com |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Evolva Holding SA Fundamentals Summary
| EVEZ fundamental statistics | |
|---|---|
| Market cap | CHF7.28m |
| Earnings (TTM) | -CHF101.22m |
| Revenue (TTM) | CHF4.16m |
1.8x
P/S Ratio-0.1x
P/E RatioIs EVEZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVEZ income statement (TTM) | |
|---|---|
| Revenue | CHF4.16m |
| Cost of Revenue | CHF0 |
| Gross Profit | CHF4.16m |
| Other Expenses | CHF105.37m |
| Earnings | -CHF101.22m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -14.04 |
| Gross Margin | 100.00% |
| Net Profit Margin | -2,434.99% |
| Debt/Equity Ratio | 0% |
How did EVEZ perform over the long term?
See historical performance and comparison